Postponement of Annual General Meeting. Ananda announces that, in light of the extraordinary events of recent months and in accordance with the provisions of UK Corporate Governance legislation passed on 25 June 2020, the Company intends to postpone its 2020 Annual General Meeting by up to 3 months. Ananda expects to announce the Company’ s audited results...
INCREASED EQUITY INTEREST IN iCAN ISRAEL- CANNABIS. On 8 January 2020, the first USD100, 000 of Ananda’ s convertible loan notes were converted into 120 ordinary shares in iCAN, at a valuation of USD10M for iCAN. iCAN is headquartered in Israel, one of the leading jurisdictions for medicinal cannabis research.
The Directors of Ananda Developments Plc are pleased to announce that an updated Investor Presentation is available on the Company’ s website– www.anandadevelopments.com– or on request, by emailing ir@ananadadevelopments.com.
As part of the application to grow medicinal cannabis in the UK, a meeting was held last week between DJT Plants Limited, which is 50% owned by Ananda, and the MHRA. DJT’ s ultimate objective is to be a commercial grower of medicinal cannabis for the UK and international markets. As identified by Professor Mike Barnes, a senior figure in the medicinal cannabis sector, a...
Ananda Dev 0.16p £0.7m (AQUIS:ANA) Update to shareholders. * Current application to grow medicinal cannabis will involve analysis of cannabis strains at the laboratory of Dr Dedi Meiri at The Technion in Israel * Dr Meiri is considered one of the world's foremost cannabis scientists * Dr Meiri has commenced a new project to assess the potential of the anti inflammatory properties of cannabis for treating coronaviruses * Ananda's application to grow medicinal cannabis will be broadened to stabilise strains of cannabis which may have applicability for the treatment of hyperinflammation caused by coronaviruses. These strains would be analysed at Dr Meiri's lab #ANA
The Directors of Ananda Developments Plc provide the following update to shareholders. Current application to grow medicinal cannabis will involve analysis of cannabis strains at the laboratory of Dr Dedi Meiri at The Technion in Israel. The Company’ s collaboration partner for the detailed analysis of the molecular makeup of the strains which Ananda...
Andrew Hore Quoted Micro April 13 - #ADB #ANA #AQSG #ARB #AVAP #AVO #BOU #CHH #CIR #D4T4 #EMAN #LIFE #NQMI #NTOG #SREI #RENE #SFE #SOP #SUS #TET
UPDATE ON MEDICAL CANNABIS GROWING LICENCE. In addition, the MHRA has requested a meeting to discuss the application, its research aims and objectives, and how the objectives will assist in progressing the medical cannabis sector in the UK. The practical growing will be undertaken by JEPCO, which has previously grown medical cannabis in the UK for a large...
In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, Ananda announces that the Company now has 441,097,220 ordinary shares of 0.2 p each in issue, each share carrying the right to one vote. This figure of 441,097,220 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which...
Ananda announces that 23,041,666 ordinary shares of 0.2 p each in the Company have been issued following the exercise of warrants at a price of 0.2 p per share. The warrants have been exercised by Melissa Sturgess, Chief Executive Officer of the Company. Sturgess is interested in 69,653,888 Ordinary Shares, representing 15.79 per cent of the Company’ s enlarged...
The Directors of Ananda are pleased to provide the following update to shareholders. In its negotiations with companies interested in acquiring the rights to the hapac ® technology, Liberty Herbal Technologies Limited became aware that its large capacity hapac ® sachet making machine, with an output of 4,000 sachets per hour at a capital cost of...
The Directors of Ananda are pleased to provide the following update to shareholders. In its negotiations with companies interested in acquiring the rights to the hapac ® technology, Liberty Herbal Technologies Limited became aware that its large capacity hapac ® sachet making machine, with an output of 4,000 sachets per hour at a capital cost of...
The Company is pleased to announce that iCAN has secured additional financing from Tress Capital Limited and Plaza Capital Limited through a convertible Loan note at a pre-money valuation for iCAN of USD20m. Ananda invested USD200, 000 in convertible loan notes issued by iCAN in August 2018. On 8 January 2020, USD100, 000 of Ananda’ s convertible loan notes were...
He received nine commendations and was also awarded a Winston Churchill Fellowship to examine ways to reduce drug related crime in the UK, with some of his proposals being implemented by the British Government. Peter has a Master’ s degree in Social Sciences from Exeter University. Peter has also served as a police adviser to a UK based Drug and Alcohol charity,...
In March 2019, iCAN raised a further CAD $4,000,000 from a group of Canadian investors via a loan note that is convertible into shares at a valuation of USD $20,000,000. Ananda holds USD $200,000 of loan notes convertible at a maximum valuation of USD $12,000,000. LHT launched hapac ® in Italy in late 2018.
CORPORATE UDPATE- CANNABIS CULTIVATION AND LICENCE APPLICATION. The directors of Ananda are pleased to provide the following update to shareholders. The submission contained all pertinent information regarding DJT Plants’ proposed growing operations in the UK.
CORPORATE UDPATE- CANNABIS CULTIVATION AND LICENCE APPLICATION. The directors of Ananda are pleased to provide the following update to shareholders. The submission contained all pertinent information regarding DJT Plants’ proposed growing operations in the UK.
The company was founded by Lorne Gertner, chairman and co-founder of the cannabis lifestyle brand Tokyo Smoke which was sold to Canopy Growth as part of a $250 m purchase of Haiku Brands in 2018.. MoCanna’ s first initiative is byMinistry, a cannabis centric lounge and cultural space to be opened in Toronto in late 2019. byMinistry’ s mission is to broaden and...
Andrew Hore @Hubinvest Quoted Micro 30 September 2019 #SHEP #BARK #KEP #BUD #NMRP #KDNC #PRIM #SMAP #LIFE #ANA #COIN #FSEN #PALM #NQMI #MMX #PTRO #MNO #ESC #EVE #SUS #MOSB #IDP #TXH #AIM #NEX #LSE #smallcaps #stockstowatch #StocksToTrade
CORPORATE UDPATE- CANNABIS CULTIVATION AND EXTRACTION. The directors of Ananda are pleased to provide the following update to shareholders. Application for Home Office licence to grow > 0.2% THC cannabis.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    329.17M

Featured Media

Company Profile

The Company has been established as a company to invest in the developing market for medicinal or therapeutic Cannabis derivatives, or related products, including but not limited to nutraceuticals, dietary supplements and cosmetic products which contain Cannabis or hemp derived cannabinoids. The Directors believe that this market is growing due to an increasing number of states in the USA, as well as other countries around the world, changing their laws to allow for products containing constituents of Medicinal Cannabis to be developed, approved and sold. Ananda’s investment strategy is to invest in companies, projects or products that are either progressing medicinal or therapeutic Cannabis research and development, or are developing or have already developed, products that contain Cannabis derived cannabinoids and require funding to progress work plans or commercialise products.

Classification

Market Indices-
Watchlist